Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Abeona Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ABEO alertsJoseph Vazzano is recorded as CFO at Abeona Therapeutics Inc. (ABEO). The newest filing on record that lists Joseph Vazzano as CFO at Abeona Therapeutics Inc. (ABEO) is dated April 27, 2026. Earlier roles on record: CFO at Avenue Therapeutics, Inc. (ATXI) until January 14, 2022. The proxy statement of Avenue Therapeutics, Inc. reports total compensation of $21,335 for Joseph Vazzano in fiscal 2022, including a base salary of $20,514. Disclosed compensation is on record for 5 fiscal years. Joseph Vazzano has spoken on 4 earnings calls across 1 company, most recently for Abeona Therapeutics Inc. on May 13, 2026. Abeona Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Abeona Therapeutics Inc. includes Michael Amoroso (CEO, Chairman, COO and Board Member), Vishwas Seshadri (CEO and Board Member), Brian J.G. Pereira (Chairman and Board Member) and 7 others.
“Good morning, and thank you for joining us on our first quarter 2026 results and business update conference call.”
“I would like to remind everyone that the Form 10Q is available on our website, which is where you can get additional details on our financial results for the three and nine months ended September 30, 2023.”
“I would like to remind everyone that the Form 10-Q is available on our website, which is where you can get additional details on our financial results for the three months ended June 30, 2022.”
“I would like to remind everyone that the Form 10-Q is available on our website, which is where you can get additional details on our financial results for the three months ended March 31, 2022.”
Start not stated–present
Last confirmed April 27, 2026
Start not stated–2022-01-14
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Financial Officer | $20,514 | $21,335 |
| 2021 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Financial Officer | $255,747 | $441,325 |
| 2020 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $206,000 | $214,890 |
| 2019 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $198,113 | $258,779 |
| 2018 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $175,100 | $354,528 |